Debiopharm Group (Debiopharm) is a family-owned biopharmaceutical group of companies headquartered in Lausanne, Switzerland. It was founded in 1979 by Rolland-Yves Mauvernay. The group works through its subsidiaries: As of 2010 two drugs had reached the market through its efforts: oxaliplatin for the treatment of cancer, and depot formulations of triptorelin, a gonadotropin-releasing hormone agonist that is used to treat prostate cancer and pedophilia in men, and in women, breast cancer, ovarian cancer, endometriosis, uterine fibromyomas, precocious puberty, and female infertility.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:foundationPlace | |
| dbo:foundingYear |
|
| dbo:industry | |
| dbo:location | |
| dbo:numberOfEmployees |
|
| dbo:type | |
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageRevisionID |
|
| dbp:areaServed |
|
| dbp:founder |
|
| dbp:owner |
|
| dbp:slogan |
|
| dct:subject | |
| http://purl.org/linguistics/gold/hypernym | |
| georss:point |
|
| rdf:type |
|
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| geo:geometry |
|
| geo:lat |
|
| geo:long |
|
| prov:wasDerivedFrom | |
| foaf:homepage | |
| foaf:isPrimaryTopicOf | |
| foaf:name |
|
| is dbo:wikiPageRedirects of | |
| is dbp:data of | |
| is foaf:primaryTopic of |
